Bridging Science and Investment: LIFE BioCEEd Partners with Wrocław University of Science and Technology
Exploring the untapped potential of Czech and regional science, LIFE BioCEED seeks to transform hidden discoveries into life-changing impact.
First investment targets groundbreaking treatment for Netherton syndrome
LIFE BioCEEd has signed a Memorandum of Cooperation with the Centre for Advanced Materials Application of the Slovak Academy of Sciences (CEMEA SAV, v.v.i.) to connect advanced materials research with biomedical innovation.
What once seemed like research destined to end in a drawer has turned into one of the largest biotech deals in recent years.
Protože tech transfer vytváří konkurenční výhody, vyšší přidanou hodnotu a tím bohatší národ.
Primecell, a biotechnology company owned by one of the founders of LIFE BioCEEd, has sold a majority stake in two biotechnology companies. These were acquired by VITA 34, the global leader in the field, based in Germany. The transaction, whose key value lies in its expertise in cell therapy, is one of the most significant in the Czech biotechnology sector in the last 20 years.
The partnership aims to accelerate the development and commercialization of academic healthcare and biotech innovations in Central Europe.
With CZK 500 million in backing and partnerships across CEE universities and research institutes, LIFE BioCEEd scouts, develops and commercializes breakthrough medical inventions.
Strategic MoU to support the development and commercialization of healthtech and biomedical innovations
LIFE BioCEEd and CTT MUG Enter Strategic Cooperation to Advance Biomedical Innovation
LIFE bioCEEd and University Hospital Hradec Králové Sign Memorandum of Cooperation to Accelerate the Transfer of Medical Innovations into Clinical Practice
A new investment firm, LIFE BioCEEd, has raised half a billion Czech crowns to convert medical and biotech discoveries from Central and Eastern Europe (CEE) into market-ready solutions. Co-founder Michal Zahradníček explains how the company’s expertise in science, patient needs, and commercialization helps unlock CEE’s innovation potential, aiming to deliver both strong returns and breakthroughs in healthcare quality.
LIFE bioCEEd hosts its first shareholder meeting at Betlémský Palác marking its official launch.
Stefan Savic, CEO of LIFE bioCEEd, shares the company’s journey in the January issue of Forbes Česko.
